The launch, scheduled for June 15, 2026, marks a shift for the company toward comprehensive gut intelligence. Professor Paul Clayton, LYMA’s director of science, argues that current market offerings are fundamentally incomplete because they fail to provide the prebiotic diversity required to colonize the entire digestive tract. ID² addresses this with 8.5g of multi-length prebiotic fibers, intended to feed the colon from the proximal to the distal end, rather than just isolated chambers.

Beyond basic digestion, the formula incorporates algae-derived DHA and Oleacore olive polyphenols to protect cellular integrity and support sirtuin activation. This structural approach is designed to improve the absorption of over 25 chelated vitamins and minerals, which the brand claims are often wasted in the oxide forms typically found in mass-market supplements. The product arrives as the industry grapples with the nutritional gaps left by GLP-1 weight-loss medications, positioning itself as a way to ensure systemic nutritional coverage regardless of reduced food intake.

Retail availability begins exclusively at lyma.life, with a subsequent rollout at Harrods in London and a series of pop-up activations at SoulCycle Hamptons. The 30-day supply is priced at £125 or $175, reflecting the brand’s established strategy of positioning itself at the intersection of clinical science and luxury wellness.